Your browser doesn't support javascript.
loading
Rapid Desensitization for Hypersensitivity Reactions to Chemotherapeutic Drugs; A Case Series.
Babaie, Delara; Shamsian, Bibi Shahin; Momtazmanesh, Nader; Godarzipour, Hamidreza; Amirmoini, Mehrdad; Bashardoust, Bahram; Ebrahimi, Masoomeh; Vahedi, Mahdieh; Ghaemi, Reza; Mesdaghi, Mehrnaz.
Afiliación
  • Babaie D; Department of Immunology and Allergy, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Shamsian BS; Pediatric Congenital Hematologic Disorders Research Center, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Momtazmanesh N; Department of Pediatric Hematology and Oncology, Loghman-e- Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Godarzipour H; Pediatric Congenital Hematologic Disorders Research Center, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Amirmoini M; Department of Immunology and Allergy, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Bashardoust B; Department of Immunology and Allergy, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Ebrahimi M; Department of Pediatrics, Loghman-e- Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Vahedi M; Department of Pediatrics, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Ghaemi R; Department of Pediatrics, Urmia University of Medical Sciences, Urmia, Iran.
  • Mesdaghi M; Department of Immunology and Allergy, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Iran J Pharm Res ; 18(2): 1047-1051, 2019.
Article en En | MEDLINE | ID: mdl-31531085
ABSTRACT
Usage of cancer chemotherapeutics drugs can be associated with adverse drug reactions. When IgE-mediated drug reactions are formed following administration of a chemotherapeutics drug that is a drug of choice, drug desensitization protocols can be helpful. HSR can be allergic or nonallergic, but the clinical manifestations are similar. RDD is effective when used appropriately, however it is often over utilized instead of performing a drug challenge. RDD is both an acceptable approach and a high-risk treatment modality in patients, in whom the offending agent is the first choice in chemotherapy. The safety of this modality has been acceptable in large studies. The side effects are often less frequent and less severe by repeating the protocol. We present 4 cases of successful desensitization in cancer patients, who have developed IgE- mediated reactions to their major chemotherapy drug.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Iran J Pharm Res Año: 2019 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Iran J Pharm Res Año: 2019 Tipo del documento: Article País de afiliación: Irán